US Patent Issued to Atom Therapeutics on June 17 for "Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alphapyridine-3-carbonyl)-2-hydroxybenzonitrile" (Chinese, American Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,047, issued on June 17, was assigned to Atom Therapeutics Co. Ltd (Hangzhou, China).

"Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alphapyridine-3-carbonyl)-2-hydroxybenzonitrile" was invented by Dongfang Shi (Fremont, Calif.), Changjin Fu (Suzhou, China), Jie Gu (Suzhou, China), Min Zhang (Suzhou, China), Weiwei Gong (Suzhou, China) and Pengfei Li (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for synthesizing 3-bromo-5-(2-ethylimidazo[1,2-a] pyridine-3-carbonyl)-2-hydroxybenzonitrile, particularly relates to a method for synthesizing a compound represented by a formula (III), and particularly relates to step A or step B; st...